Free Trial

Ernexa Therapeutics (ERNA) News Today

Ernexa Therapeutics logo
$1.39 -0.10 (-6.71%)
Closing price 04:00 PM Eastern
Extended Trading
$1.48 +0.09 (+6.12%)
As of 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ERNA Latest News

Ernexa Therapeutics Closes New Funding Round
Eterna changes name to Ernexa Therapeutics
Eterna hosts inaugural meeting of newly formed SAB
Eterna appoints Zeldis, Sather to scientific advisory board
Eterna Therapeutics Appoints Dr. Elena Ratner To Board Of Directors
Eterna Therapeutics Inc Ordinary Shares
Eterna launches research to evaluate ERNA-101
Eterna Therapeutics Authorized $1 Mln Share Buyback; Stock Up In Pre-market
Eterna Therapeutics Announces Up to $1 Million Stock Repurchase Program
Eterna regains compliance with Nasdaq
Eterna files to sell 49.87M shares of common stock for holders
Eterna completes strategic financial restructuring
Eterna, Factor announce license, collaboration agreement
Eterna Therapeutics Inc. (ERNA)
Q4 2023 Cognition Therapeutics Inc Earnings Call
Get Ernexa Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ERNA and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ERNA Media Mentions By Week

ERNA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ERNA
News Sentiment

1.88

0.97

Average
Medical
News Sentiment

ERNA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ERNA Articles
This Week

1

0

ERNA Articles
Average Week

Get the Latest News and Ratings for ERNA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ernexa Therapeutics and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:ERNA) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners